In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tom Gallen

Managing Editor – Europe

Having joined OTC bulletin as a business reporter in 2013, Tom is currently the managing editor and has an intimate knowledge of the global consumer healthcare market, particularly commercial and regulatory issues. He specializes in analyzing the strategies of the world's leading consumer healthcare companies, their business performance, plans and product portfolios.

Latest From Tom Gallen

Bayer Cements Supplement Sales Gains From Initial COVID Boost

A year on from the start of the COVID-19 outbreak and a global rush for supplements, Bayer has cemented these sales gains with slight growth at its Nutritionals business in Q1.

Sales & Earnings International

Nestlé Snaps Up US-Based Hydration Supplements Specialist Nuun

Nestlé Health Science is acquiring hydration supplements specialist Nuun, which claims to be the number-one selling sports drink supplement brand in running, cycling, outdoor and natural foods stores in the US.

United States Deals

Common Dietary Supplement Additive Ruled Unsafe By EU Regulator

Titanium dioxide - used as a colorant in many dietary supplements - is no longer considered safe when used as a food additive, says the European Food Safety Authority. The European Commission and EU member states must now decide whether to follow France's lead and ban its use in foods outright. 

Europe Dietary Supplements

People On The Move: Appointments At UPSA, Bionorica And MHRA

The latest European consumer health people news: Sanofi Consumer Healthcare's Van Rycke named CEO of UPSA; Bionorica's global business head steps down; MHRA names its first chief safety officer.

Appointments Leadership

Swisse Pens Deal To Use ChromaDex’ Niagen In Supplements

Australian-heritage supplements brand Swisse has secured the rights to use ChromaDex' patented Niagen ingredient - marketed to help consumers "age better" - in a new product range.

Deals China

LATAM Q1 Sales: Mexico's Genomma And Brazil's Hypera Report Gains

Genomma Lab reports OTC sales rise in Q1 thanks to gains in its LATAM region, while Brazil's Hypera posts big jump in turnover due to acquisitions. 

Sales & Earnings Mexico
See All
UsernamePublicRestriction

Register